Literature DB >> 22966269

T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness.

Geane Moreira1, Lívia Bonfim Fulgêncio, Elismauro Francisco DE Mendonça, Cláudio Rodrigues Leles, Aline Carvalho Batista, Tarcília Aparecida DA Silva.   

Abstract

Tumor-infiltrating lymphocytes (TILs) are a heterogeneous cell family which plays an important role in tumor-associated immune response. Of these, T regulatory (Treg) cells have also been shown to inhibit anti-tumor response. We aimed to evaluate the expression of T regulatory cell markers (CD4, CD25, CTLA-4 and FoxP3) in samples of oral cavity squamous cell carcinoma (OCSCC) and lip SCC (LSCC) by immunohistochemistry. The relationship of Treg markers with survival data and the proliferative index were also evaluated. We observed similar numbers of CD4-, CD25- and FoxP3(+) cells in OCSCC and LSCC. On the other hand, numbers of CTLA-4(+) cells were significantly lower in OCSCC than in LSCC. OCSCC samples with high numbers of CD4 exhibited a high proliferative index, while samples with high CTLA-4 counts demonstrated a low tumoral proliferative index. A log-rank test showed that patients with OCSCC that presented high counts of CD4 showed a significantly decreased survival compared with patients with low cell counts. In contrast, high CD25(+) cell counts were associated with increased survival. Our results suggest an association of CD4 with poor prognosis, while CD25 expression is related with favorable prognosis. These findings result from the heterogeneity of TIL subsets that display an antagonistic role in tumor immune cell response.

Entities:  

Year:  2010        PMID: 22966269      PMCID: PMC3436214          DOI: 10.3892/ol_00000023

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  41 in total

1.  Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck.

Authors:  Jose Guilherme Vartanian; André Lopes Carvalho; Manoel José de Araújo Filho; Mituro Hattori Junior; José Magrin; Luiz Paulo Kowalski
Journal:  Oral Oncol       Date:  2004-02       Impact factor: 5.337

2.  Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma.

Authors:  Y-K Wong; K-W Chang; C-Y Cheng; C-J Liu
Journal:  J Oral Pathol Med       Date:  2006-01       Impact factor: 4.253

3.  The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Authors:  Dominik Wolf; Anna M Wolf; Holger Rumpold; Heidi Fiegl; Alain G Zeimet; Elisabeth Muller-Holzner; Martina Deibl; Guenther Gastl; Eberhard Gunsilius; Christian Marth
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

4.  B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.

Authors:  Xue-Feng Bai; Jinqing Liu; Kenneth F May; Yong Guo; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

5.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

6.  Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.

Authors:  Stephanie G Downey; Jacob A Klapper; Franz O Smith; James C Yang; Richard M Sherry; Richard E Royal; Udai S Kammula; Marybeth S Hughes; Tamika E Allen; Catherine L Levy; Michael Yellin; Geoffrey Nichol; Donald E White; Seth M Steinberg; Steven A Rosenberg
Journal:  Clin Cancer Res       Date:  2007-11-02       Impact factor: 12.531

7.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

8.  Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumors.

Authors:  Douglas Hanahan; Antonio Lanzavecchia; Enrico Mihich
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

9.  Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells.

Authors:  Wei-Zen Wei; Gerald P Morris; Yi-Chi M Kong
Journal:  Cancer Immunol Immunother       Date:  2003-11-11       Impact factor: 6.968

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  5 in total

Review 1.  TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?

Authors:  Astrid De Meulenaere; Tijl Vermassen; Sandrine Aspeslagh; Katrien Vandecasteele; Sylvie Rottey; Liesbeth Ferdinande
Journal:  Head Neck Pathol       Date:  2016-12-28

2.  The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part I: B7-H1 (PD-L1) and B7-DC (PD-L2).

Authors:  Anna Starzyńska; Aleksandra Sejda; Łukasz Adamski; Paulina Adamska; Rafał Pęksa; Monika Sakowicz-Burkiewicz; Piotr Wychowański; Barbara A Jereczek-Fossa
Journal:  Postepy Dermatol Alergol       Date:  2020-10-13       Impact factor: 1.664

Review 3.  The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.

Authors:  Emma J de Ruiter; Marc L Ooft; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2017-08-09       Impact factor: 8.110

4.  Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer.

Authors:  Wan-Yu Chen; Chen-Tu Wu; Chun-Wei Wang; Keng-Hsueh Lan; Hsiang-Kuang Liang; Bing-Shen Huang; Yih-Leong Chang; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  Radiat Oncol       Date:  2018-08-28       Impact factor: 3.481

5.  Characterization of immune cell infiltrate in tumor stroma and epithelial compartments in oral squamous cell carcinomas of Sudanese patients.

Authors:  Nuha Mohamed Gaafar; Tarig Al-Hadi Osman; Israa Abdulrahman Ahmed; Mariam Elsheikh; Harsh Dongre; Martha Rolland Jacobsen; Nazar Gafar Mohamed; Siren Fromreide; Ahmed Mohamed Suleiman; Anne Christine Johannessen; Elisabeth Sivy Nginamau; Daniela Elena Costea
Journal:  Clin Exp Dent Res       Date:  2021-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.